Skip to content
ClinCalc Pro
Menu
IV iron

Ferric derisomaltose

Brand names: Monofer

Ferric derisomaltose is a parenteral (intravenous) iron preparation used to treat iron-deficiency anaemia when oral iron is ineffective, not tolerated or rapid replacement is needed.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It delivers iron within a carbohydrate complex that is taken up by the reticuloendothelial system, releasing iron for incorporation into haemoglobin and replenishment of stores.

Prescribing in practice

  • Serious hypersensitivity and anaphylactic reactions can occur, so it must be given where resuscitation facilities are available and the patient observed during and after administration.
  • Avoid in the first trimester of pregnancy and use parenteral iron in later pregnancy only when clearly necessary.
  • Extravasation can cause persistent brown skin staining, so infusion site care is important.

Monitoring

Monitor the patient closely for hypersensitivity during and after the infusion and reassess iron indices and haemoglobin to gauge response.

Counselling the patient

  • Report any rash, breathlessness, swelling or feeling unwell during or after the infusion immediately.
  • Tell the team about any previous reactions to intravenous iron.
  • Some people experience temporary symptoms such as headache or altered taste.

Evidence & guidelines

Intravenous iron is recommended where oral iron is unsuitable or replacement must be rapid, consistent with NICE and MHRA advice on managing iron-deficiency anaemia and parenteral iron safety.

Reference: NICE NG8; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.